Acumen Pharmaceuticals
$2.25
38
-$0.04-1.75% Wednesday 20:00
Statistics
Day High
2.43
Day Low
2.21
52W High
3.6
52W Low
1.1
Volume
947,294
Avg. Volume
-
Mkt Cap
136.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
17AugExpected
Expected EPS
-0.359333
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-204.66MNet Income
Analyst Ratings
8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ABOS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap29.53B
Lilly(Eli) &
LLY
Mkt Cap1.01T
Anavex Life Sciences
AVXL
Mkt Cap231.68M
Prothena
PRTA
Mkt Cap426.68M
Cass Information Systems
CASS
Mkt Cap636.48M
Alnylam Pharmaceuticals
ALNY
Mkt Cap37.76B
Curis
CRIS
Mkt Cap16.21M
About
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
Show more...
CEO
Mr. Daniel J. O'Connell M.B.A.
Employees
61
Country
United States
ISIN
US00509G2093
Listings
0 Comments
Share your thoughts
FAQ
What is Acumen Pharmaceuticals stock price today?▼
The current price of ABOS is $2.25 USD — it has decreased by -1.75% in the past 24 hours. Watch Acumen Pharmaceuticals stock price performance more closely on the chart.
What is Acumen Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acumen Pharmaceuticals stocks are traded under the ticker ABOS.
Is Acumen Pharmaceuticals stock price growing?▼
ABOS stock has fallen by -5.06% compared to the previous week, the month change is a +3.21% rise, over the last year Acumen Pharmaceuticals has showed a +84.43% increase.
What is Acumen Pharmaceuticals market cap?▼
Today Acumen Pharmaceuticals has the market capitalization of 136.29M
When is the next Acumen Pharmaceuticals earnings date?▼
Acumen Pharmaceuticals is going to release the next earnings report on August 17, 2026.
What were Acumen Pharmaceuticals earnings last quarter?▼
ABOS earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.4 USD resulting in a +18.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Acumen Pharmaceuticals revenue for the last year?▼
Acumen Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Acumen Pharmaceuticals net income for the last year?▼
ABOS net income for the last year is -204.66M USD.
How many employees does Acumen Pharmaceuticals have?▼
As of June 18, 2026, the company has 61 employees.
In which sector is Acumen Pharmaceuticals located?▼
Acumen Pharmaceuticals operates in the Health & Wellness sector.
When did Acumen Pharmaceuticals complete a stock split?▼
Acumen Pharmaceuticals has not had any recent stock splits.
Where is Acumen Pharmaceuticals headquartered?▼
Acumen Pharmaceuticals is headquartered in Newton, United States.